179 related articles for article (PubMed ID: 35661571)
1. Analyzing excipient-related adverse events in antiseizure drug formulations.
Ionova Y; Peterson T; Wilson L
Epilepsy Res; 2022 Aug; 184():106947. PubMed ID: 35661571
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database.
Kim HK; Jang KS; Kim DW
Epilepsy Behav; 2024 May; 154():109784. PubMed ID: 38636107
[TBL] [Abstract][Full Text] [Related]
3. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
Knight R; Wittkowski A; Bromley RL
Epilepsia; 2021 Aug; 62(8):1765-1779. PubMed ID: 34128227
[TBL] [Abstract][Full Text] [Related]
5. [Antiepileptic drugs in North America].
Akiyama T; Otsubo H
Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Basis of Generic Substitution of Antiseizure Medications.
Elmer S; Reddy DS
J Pharmacol Exp Ther; 2022 May; 381(2):188-196. PubMed ID: 35241634
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model.
Choi SA; Kim H; Kim S; Yoo S; Yi S; Jeon Y; Hwang H; Kim KJ
Epilepsia; 2020 Apr; 61(4):610-616. PubMed ID: 32162687
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin add-on for drug-resistant focal epilepsy.
Panebianco M; Bresnahan R; Hemming K; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
[TBL] [Abstract][Full Text] [Related]
10. Pediatric adverse reactions to antiseizure medications - An analysis of data from the Italian spontaneous reporting system (2001-2019).
Franco V; Barbieri MA; Cutroneo PM; Arena I; Cicala G; Marchione P; Spina E; Perucca E
Epilepsy Behav; 2021 Jun; 119():107989. PubMed ID: 33946010
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660
[TBL] [Abstract][Full Text] [Related]
12. Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.
Załuska-Ogryzek K; Marzęda P; Wróblewska-Łuczka P; Florek-Łuszczki M; Plewa Z; Bojar H; Zolkowska D; Łuszczki JJ
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073930
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity of newer antiseizure medications in children: an overview and disproportionality analysis of VigiBase.
Petrović S; Kovačević M; Kovačević SV; Miljković B
Expert Opin Drug Metab Toxicol; 2024 Mar; 20(3):165-173. PubMed ID: 38380611
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment.
Tensini TS; Von Glehn CQC; Bettinotti MP; Iglehart B; de Paola L; Lohr A; Rodrigues M; Tensini FS; Braatz VL; Silvado CES
Epileptic Disord; 2021 Jun; 23(3):466-475. PubMed ID: 34080983
[TBL] [Abstract][Full Text] [Related]
16. Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.
Socała K; Wyska E; Szafarz M; Nieoczym D; Wlaź P
Neuropharmacology; 2019 Nov; 158():107733. PubMed ID: 31377197
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Odi R; Franco V; Perucca E; Bialer M
Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
[TBL] [Abstract][Full Text] [Related]
18. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
Terman SW; Youngerman BE; Choi H; Burke JF
Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
[TBL] [Abstract][Full Text] [Related]
19. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database.
Porwal MH; Razzak AN; Kumar V; Obeidat AZ; Sharma U
Epilepsy Res; 2024 Jul; 203():107382. PubMed ID: 38761467
[TBL] [Abstract][Full Text] [Related]
20. Caffeine and Its Interactions with Antiseizure Medications-Is There a Correlation between Preclinical and Clinical Data?
Miziak B; Błaszczyk B; Chrościńska-Krawczyk M; Czuczwar SJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
